Research Article

The Efficacy of Long-Term Chinese Herbal Medicine Use on Lung Cancer Survival Time: A Retrospective Two-Center Cohort Study with Propensity Score Matching

Table 1

Clinical assessment of participants before and after PSM.

ItemBefore PSM valueAfter PSM value
CHM group (n = 761)Control group (n = 373)CHM group (n = 208)Control group (n = 208)

Gender
 Male389 (51.1)246 (66.7)<0.001119 (57.2)115 (55.3)0.693
 Female372 (48.9)128 (34.3)89 (42.8)93 (44.7)
Age
 ≤60315 (41.4)186 (49.9)0.00791 (43.8)93 (44.7)0.843
 >60446 (58.6)187 (50.1)117 (56.2)115 (55.3)
Pathology
 Unspecified43 (5.7)1 (0.2)<0.0011 (0.5)1 (0.5)0.927
 Adenocarcinoma546 (71.7)235 (63.0)151 (72.6)143 (68.8)
 Squamous cell cancer87 (11.4)90 (24.1)33 (15.9)39 (18.8)
 Small cell lung cancer29 (3.8)31 (8.3)12 (5.8)12 (5.8)
 Others56 (7.4)16 (4.3)11 (5.3)13 (6.3)
Stage
 I295 (38.8)193 (51.7)<0.00199 (47.6)93 (44.7)0.842
 II39 (5.1)35 (9.4)18 (8.7)22 (10.6)
 IIIA47 (6.2)56 (15.0)23 (11.1)29 (13.9)
 IIIB41 (5.4)51 (13.7)28 (13.5)27 (13.0)
 IV339 (44.5)37 (9.9)40 (19.2)37 (17.8)
Surgery
 Yes367 (48.2)251 (67.3)<0.001134 (64.4)132 (63.5)0.838
 No394 (51.8)122 (32.7)74 (35.6)76 (36.5)
Chemotherapy
 Yes337 (44.3)293 (78.6)<0.001142 (68.3)128 (60.1)0.150
 No424 (55.7)80 (21.4)66 (31.7)80 (38.5)
Radiotherapy
 Yes115 (15.1)70 (18.8)0.11837 (17.8)33 (15.9)0.600
 No646 (84.9)303 (81.2)171 (82.2)175 (84.1)
Interventional therapy
 Yes9 (1.2)5 (1.3)0.8215 (2.4)4 (1.9)0.736
 No752 (98.8)368 (98.7)203 (97.6)204 (98.1)
Targeted therapy
 Yes124 (16.3)34 (9.1)0.00127 (13.0)24 (11.5)0.654
 No637 (83.7)339 (90.9)181 (87.0)184 (88.5)
Family history
 Yes207 (27.2)11 (2.9)<0.00110 (4.8)11 (5.3)0.823
 No554 (72.8)362 (97.1)198 (95.2)197 (94.7)
Smoking
 Yes251 (33.0)99 (26.5)0.02763 (30.3)71 (34.1)0.401
 No510 (67.0)274 (73.5)145 (69.7)137 (65.9)
Drinking
 Yes77 (10.1)23 (6.2)0.02718 (8.7)21 (10.1)0.614
 No684 (89.9)350 (93.8)190 (91.3)187 (89.9)

PSM: propensity score matching; , a significantly statistical difference in subgroup.